Advisor Group Holdings, Inc. 2seventy Bio, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,886 shares of TSVT stock, worth $7,503. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,886
Previous 2,842
1.55%
Holding current value
$7,503
Previous $13,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TSVT
# of Institutions
127Shares Held
44.8MCall Options Held
17.3KPut Options Held
2.9K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$15.5 Million1.11% of portfolio
-
Goldman Sachs Group Inc New York, NY4.29MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$9.78 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$9.52 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.92MShares$7.59 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $98.5M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...